Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis

被引:17
作者
Endoh, Kanji [2 ]
Nishi, Mayuko
Ishiguro, Hitoshi [3 ,4 ]
Uemura, Hiroji [3 ]
Miyagi, Yohei [5 ]
Aoki, Ichiro [6 ]
Hirano, Hisashi [7 ]
Kubota, Yoshinobu [3 ]
Ryo, Akihide [1 ]
机构
[1] Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Taiho Pharmaceut Co Ltd, Drug Discovery Res Ctr, Tsukuba, Ibaraki, Japan
[3] Yokohama City Univ, Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan
[4] Kanagawa Acad Sci & Technol, Photocatalyst Grp, Takatsu Ku, Kawasaki, Kanagawa, Japan
[5] Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, Yokohama, Kanagawa 2410815, Japan
[6] Yokohama City Univ, Sch Med, Dept Mol Pathol, Yokohama, Kanagawa 2360004, Japan
[7] Yokohama City Univ, Dept Nanobiosci, Yokohama, Kanagawa 2360004, Japan
关键词
prostate cancer; tumor recurrence; androgen receptor; prognostic marker; PROLYL ISOMERASE PIN1; RECURRENCE; PROTEOMICS; INHIBITOR; SYSTEM; KINASE;
D O I
10.1002/pros.21466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The peptidyl-prolyl isomerase Pin1 regulates a subset of phosphorylated proteins by catalyzing the cis-trans isomerization of their specific phosphorylated Ser/Thr-Pro motifs. Although Pin1 has been shown to be involved in cell transformation and the maintenance of the malignant phenotype in prostate cancer, its specific substrates during these processes have not yet been determined. METHODS. Cancer-specific phosphorylated proteins were isolated from two human prostate cancer cell lines (PC-3, LNCaP) and the Dunning rat prostate cancer cell lines by GST-pull down analysis with recombinant GST-Pin1 protein. These proteins were then identified by the LC-MS/MS analysis using a Q-Tof micro mass spectrometer and processed for further functional analysis. RESULTS. We newly identified five prostate cancer-specific Pin1 binding proteins (PINBPs) in this screen. Among these, TRK-fused gene (TFG) was found to be preferentially up-regulated in prostate cancer cell lines and tissues. The targeted inhibition of TFG by specific siRNA resulted in the reduced cell proliferation and the induction of premature senescence in PC3 prostate cancer cells. We further found that TFG can facilitate the cell signaling mediated by NF-kappaB and androgen receptor (AR). Tissue micro-dissection based quantitative RT-PCR analysis of prostate cancer tissues following radical prostatectomy further revealed that TFG expression is closely associated with both a higher probability and shorter period of tumor recurrence following surgery. CONCLUSIONS. Pin1-based proteomics analysis is a useful tool for the identification of prostate cancer-specific phosphorylated proteins. TFG could be a potential diagnostic and/or prognostic marker and therapeutic target in prostate cancer. Prostate 72:626-637, 2012. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:626 / 637
页数:12
相关论文
共 25 条
[1]   Molecular genetics of prostate cancer [J].
Abate-Shen, C ;
Shen, MM .
GENES & DEVELOPMENT, 2000, 14 (19) :2410-2434
[2]  
[Anonymous], J BIOL CHEM
[3]  
Ayala G, 2003, CANCER RES, V63, P6244
[4]   EXPRESSION OF RAS PROTO-ONCOGENES IN THE DUNNING R3327 RAT PROSTATIC ADENOCARCINOMA SYSTEM [J].
COOKE, DB ;
QUARMBY, VE ;
PETRUSZ, P ;
MICKEY, DD ;
DER, CJ ;
ISAACS, JT ;
FRENCH, FS .
PROSTATE, 1988, 13 (04) :273-287
[5]   Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes [J].
Cookson, Michael S. ;
Aus, Gunnar ;
Burnett, Arthur L. ;
Canby-Hagino, Edith D. ;
D'Amico, Anthony V. ;
Dmochowski, Roger R. ;
Eton, David T. ;
Forman, Jeffrey D. ;
Goldenberg, S. Larry ;
Hernandez, Javier ;
Higano, Celestia S. ;
Kraus, Stephen R. ;
Moul, Judd W. ;
Tangen, Catherine ;
Thrasher, J. Brantley ;
Thompson, Ian .
JOURNAL OF UROLOGY, 2007, 177 (02) :540-545
[6]   Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment [J].
De Marzo, AM ;
DeWeese, TL ;
Platz, EA ;
Meeker, AK ;
Nakayama, M ;
Epstein, JI ;
Isaacs, WB ;
Nelson, WG .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (03) :459-477
[7]   Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling [J].
Fang, Bin ;
Haura, Eric B. ;
Smalley, Keiran S. ;
Eschrich, Steven A. ;
Koomen, John M. .
BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) :739-747
[8]   TUMOR-NECROSIS-FACTOR TYPE-ALPHA, A POTENT INHIBITOR OF ENDOTHELIAL-CELL GROWTH-INVITRO, IS ANGIOGENIC INVIVO [J].
FRATERSCHRODER, M ;
RISAU, W ;
HALLMANN, R ;
GAUTSCHI, P ;
BOHLEN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (15) :5277-5281
[9]   A Worldwide Approach to the TNM Staging System: Collaborative Efforts of the AJCC and UICC [J].
Greene, Frederick L. ;
Sobin, Leslie H. .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (05) :269-272
[10]   Shotgun Proteomics of the Haloarchaeon Haloferax volcanii [J].
Kirkland, P. Aaron ;
Humbard, Matthew A. ;
Daniels, Charles J. ;
Maupin-Furlow, Julie A. .
JOURNAL OF PROTEOME RESEARCH, 2008, 7 (11) :5033-5039